Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
05/23/20246:00PMGlobeNewswire Inc.Huize Holding Limited Reports First Quarter 2024 Unaudited Financial ResultsNASDAQ:HUIZHuize Holding Ltd
05/23/20246:00PMGlobeNewswire Inc.Associa Recognized as a US Best Managed Company
05/23/20246:00PMBusiness WireAqua Pennsylvania Files Rate Request Based on Water and Wastewater Operations, Infrastructure Improvements and Repairs Across the CommonwealthNYSE:WTRGEssential Utilities Inc
05/23/20246:00PMGlobeNewswire Inc.Myriad Genetics Showcases New Research and Product Innovations Advancing Cancer Care at 2024 ASCO® Annual MeetingNASDAQ:MYGNMyriad Genetics Inc
05/23/20245:59PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SPTSprout Social Inc
05/23/20245:59PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NBIXNeurocrine Biosciences Inc
05/23/20245:59PMBusiness WireBrowning West annonce la réussite de sa démarche visant à remplacer tous les membres du conseil d’administration de Les Vêtements de Sport Gildan par l’ensemble de ses huit candidatsNYSE:GILGildan Activewear Inc
05/23/20245:58PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SRCLStericycle Inc
05/23/20245:58PMBusiness WireBrowning West Announces Successful Replacement of Gildan Activewear’s Entire Board of Directors with Full Eight-Member SlateNYSE:GILGildan Activewear Inc
05/23/20245:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EQEquillium Inc
05/23/20245:55PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STKSONE Group Hospitality Inc
05/23/20245:55PMGlobeNewswire Inc.Gildan Board of Directors ResignsTSX:GILGildan Activewear Inc
05/23/20245:55PMGlobeNewswire Inc.Gildan Board of Directors ResignsNYSE:GILGildan Activewear Inc
05/23/20245:55PMPR Newswire (US)Picus Security Launches Security Validation for Kubernetes
05/23/20245:55PMPR Newswire (US)SR BANCORP, INC. ANNOUNCES BALANCE SHEET REPOSITIONINGNASDAQ:SRBKSR Bancorp Inc
05/23/20245:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ADMArcher Daniels Midland Company
05/23/20245:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMZNAmazon.com Inc
05/23/20245:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SRCLStericycle Inc
05/23/20245:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STKSONE Group Hospitality Inc
05/23/20245:53PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SRCLStericycle Inc
05/23/20245:53PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AVDXAvidXchange Holdings Inc
05/23/20245:53PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:FLSFlowserve Corp
05/23/20245:53PMPR Newswire (US)Picus Security Launches Security Validation for Kubernetes
05/23/20245:53PMPR Newswire (Canada)LiuGong fait ses débuts au salon CSPI-EXPO 2024
05/23/20245:52PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SRCLStericycle Inc
05/23/20245:52PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]USOTC:CRWECrown Equity Holdings Inc (PK)
05/23/20245:52PMGlobeNewswire Inc.Acceleware Ltd. Reports First Quarter 2024 Financial and Operating ResultsTSXV:AXEAcceleware Ltd
05/23/20245:52PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NYSE:GPIGroup 1 Automotive Inc
05/23/20245:52PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SRCLStericycle Inc
05/23/20245:51PMGlobeNewswire Inc.Coherus Presents Preliminary Results from Phase I Dose Escalation Study of its Anti-chemokine receptor 8 (CCR8) Antibody, CHS-114, at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:CHRSCoherus BioSciences Inc